RE: RNS lot's of good bits to take away5 May 2021 09:57
Sales Pipeline
With the manufacturing chain falling into place, P2F is now in a position to increase its sales and marketing efforts. As prices of imported generic masks that do not contain P2F's patented anti-viral layer have fallen significantly over the last year, P2F is focusing more on specific sectors where demand is less price sensitive and more concerned with the unique utility and value of P2F's ProLarva MHRA approved, anti-viral mask. The Company is pleased to announce that it has entered into a distribution agreement with Numed Holdings Limited (www.numed.co.uk), who will supply the P2F mask into GP, dental and veterinary surgeries, opticians and care homes across the UK and Ireland. Although the strong interest displayed in 2020 in P2F's anti-viral technology has yet to translate into significant sales of the ProLarva mask in 2021, P2F is currently in discussions with several potential large customers both in the UK and overseas and hopes to be able to announce some significant orders in the near future.
yes it's all good'' although the dribble continue, and just too much information
about software problem but it will be fix next week LOL!!
anything for a drop and squeeze out the weak...
more news coming on orders next week for sure....
PATIENT..
308..